SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Monday reported a loss of $51 million in its third quarter.
On a per-share basis, the South Plainfield, New Jersey-based company said it had a loss of $1.06. Losses, adjusted for asset impairment costs, came to 94 cents per share.
The biopharmaceutical company posted revenue of $53.6 million in the period.
PTC Therapeutics shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT